Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Publication: New England Journal

von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, et al.

14 February 2019

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025